Safety and Immunogenicity Dose-finding Study of Adjuvanted SCB-2020S Vaccine in Adults (clinicaltrials.gov) - Oct 19, 2022 - P1 | N=153 | Active, not recruiting | Sponsor: Clover Biopharmaceuticals AUS Pty Ltd | Recruiting ➔ Active, not recruiting
Enrollment closed • Infectious Disease • Novel Coronavirus Disease • Respiratory Diseases
|